November 19, 2014November 19, 2014

Epic Sciences to Present CTC-cfDNA Method for Lung Cancer Analysis

News

Innovative cancer diagnostics and treatment development company, Epic Sciences, Inc., will be attending the upcoming 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona to present a poster on a ... Read more

October 29, 2014November 18, 2014

Pharmatech’s AccessPPM Research System Focuses On Lung Cancer Studies

News

After the launch of AccessPPM (Pharmatech Precision Medicine) Research System, Pharmatech is focusing on lung cancer using biomarker targeting in lung cancer studies. The company has ongoing clinical trials to assess the treatment outcomes of different molecular ... Read more